Do analysts rate HLF or USNA?

Herbalife currently has a consensus price target of $17.80, indicating a potential upside of 42.40%. Given Herbalife's stronger consensus rating and higher probable upside, equities research analysts plainly believe Herbalife is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Herbalife 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor HLF or USNA?

In the previous week, USANA Health Sciences had 1 more articles in the media than Herbalife. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Herbalife. USANA Health Sciences' average media sentiment score of 0.71 beat Herbalife's score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Herbalife 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral USANA Health Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor NATR or USNA?

In the previous week, Nature's Sunshine Products had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 2 mentions for USANA Health Sciences. Nature's Sunshine Products' average media sentiment score of 0.75 beat USANA Health Sciences' score of 0.71 indicating that Nature's Sunshine Products is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nature's Sunshine Products 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive USANA Health Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend NUS or USNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend MED or USNA?

Medifast presently has a consensus target price of $12.00, suggesting a potential upside of 14.54%. Given Medifast's higher probable upside, analysts plainly believe Medifast is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medifast 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate USNA or VERU?

Veru has a consensus price target of $23.00, indicating a potential upside of 664.12%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Veru 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable earnings & valuation, USNA or VERU?

USANA Health Sciences has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio USANA Health Sciences $925.26M 0.41 $10.76M $0.47 44.13 Veru $16.89M 2.86 -$22.73M -$0.89 N/A

USANA Health Sciences (USNA) Competitors

$20.74 +1.06 (+5.39%)

Closing price 03:59 PM Eastern

Extended Trading

$20.69 -0.05 (-0.24%)

As of 04:31 PM Eastern

Compare

USNA vs. HLF, NATR, NUS, MED, and VERU

Should you buy USANA Health Sciences stock or one of its competitors? MarketBeat compares USANA Health Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with USANA Health Sciences include Herbalife (HLF), Nature's Sunshine Products (NATR), Nu Skin Enterprises (NUS), Medifast (MED), and Veru (VERU). These companies are all part of the "personal products" industry.

How does USANA Health Sciences compare to Herbalife?

Herbalife (NYSE:HLF) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

54.3% of USANA Health Sciences shares are held by institutional investors. 5.1% of Herbalife shares are held by insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Herbalife has higher revenue and earnings than USANA Health Sciences. Herbalife is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Herbalife	$5.04B	0.26	$228.30M	$2.28	5.48
USANA Health Sciences	$925.26M	0.41	$10.76M	$0.47	44.13

In the previous week, USANA Health Sciences had 1 more articles in the media than Herbalife. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Herbalife. USANA Health Sciences' average media sentiment score of 0.71 beat Herbalife's score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Herbalife	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Herbalife has a net margin of 4.67% compared to USANA Health Sciences' net margin of 0.96%. USANA Health Sciences' return on equity of 6.21% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Herbalife	4.67%	-41.47%	8.24%
USANA Health Sciences	0.96%	6.21%	4.50%

Herbalife currently has a consensus price target of $17.80, indicating a potential upside of 42.40%. Given Herbalife's stronger consensus rating and higher probable upside, equities research analysts plainly believe Herbalife is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Herbalife	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Herbalife has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

Summary

Herbalife beats USANA Health Sciences on 10 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Nature's Sunshine Products?

Nature's Sunshine Products (NASDAQ:NATR) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Nature's Sunshine Products presently has a consensus price target of $35.00, suggesting a potential upside of 66.75%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, research analysts clearly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nature's Sunshine Products	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nature's Sunshine Products has higher earnings, but lower revenue than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nature's Sunshine Products	$489.79M	0.75	$19.52M	$1.10	19.08
USANA Health Sciences	$925.26M	0.41	$10.76M	$0.47	44.13

In the previous week, Nature's Sunshine Products had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 2 mentions for USANA Health Sciences. Nature's Sunshine Products' average media sentiment score of 0.75 beat USANA Health Sciences' score of 0.71 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nature's Sunshine Products	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nature's Sunshine Products	4.06%	14.67%	9.27%
USANA Health Sciences	0.96%	6.21%	4.50%

Nature's Sunshine Products has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Summary

Nature's Sunshine Products beats USANA Health Sciences on 14 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

In the previous week, USANA Health Sciences had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for USANA Health Sciences and 0 mentions for Nu Skin Enterprises. USANA Health Sciences' average media sentiment score of 0.71 beat Nu Skin Enterprises' score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Nu Skin Enterprises	Neutral
USANA Health Sciences	Positive

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
USANA Health Sciences	0.96%	6.21%	4.50%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nu Skin Enterprises has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.78
USANA Health Sciences	$925.26M	0.41	$10.76M	$0.47	44.13

Summary

Nu Skin Enterprises beats USANA Health Sciences on 8 of the 13 factors compared between the two stocks.

How does USANA Health Sciences compare to Medifast?

Medifast (NYSE:MED) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

95.5% of Medifast shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, USANA Health Sciences had 2 more articles in the media than Medifast. MarketBeat recorded 2 mentions for USANA Health Sciences and 0 mentions for Medifast. USANA Health Sciences' average media sentiment score of 0.71 beat Medifast's score of -1.00 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Medifast	Negative
USANA Health Sciences	Positive

Medifast presently has a consensus target price of $12.00, suggesting a potential upside of 14.54%. Given Medifast's higher probable upside, analysts plainly believe Medifast is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Medifast has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

USANA Health Sciences has a net margin of 0.96% compared to Medifast's net margin of -5.78%. USANA Health Sciences' return on equity of 6.21% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medifast	-5.78%	-4.80%	-3.83%
USANA Health Sciences	0.96%	6.21%	4.50%

USANA Health Sciences has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$385.79M	0.30	-$18.67M	-$1.83	N/A
USANA Health Sciences	$925.26M	0.41	$10.76M	$0.47	44.13

Summary

USANA Health Sciences beats Medifast on 11 of the 14 factors compared between the two stocks.

How does USANA Health Sciences compare to Veru?

USANA Health Sciences (NYSE:USNA) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Veru has a consensus price target of $23.00, indicating a potential upside of 664.12%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Veru	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

USANA Health Sciences has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Veru has a beta of -1.14, indicating that its share price is 214% less volatile than the broader market.

In the previous week, USANA Health Sciences had 1 more articles in the media than Veru. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Veru. Veru's average media sentiment score of 1.89 beat USANA Health Sciences' score of 0.71 indicating that Veru is being referred to more favorably in the news media.

Company	Overall Sentiment
USANA Health Sciences	Positive
Veru	Very Positive

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 47.2% of Veru shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 14.2% of Veru shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

USANA Health Sciences has a net margin of 0.96% compared to Veru's net margin of 0.00%. USANA Health Sciences' return on equity of 6.21% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Veru	N/A	-54.72%	-39.09%

USANA Health Sciences has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.41	$10.76M	$0.47	44.13
Veru	$16.89M	2.86	-$22.73M	-$0.89	N/A

Summary

USANA Health Sciences beats Veru on 10 of the 16 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USNA vs. The Competition

Export

Metric	USANA Health Sciences	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$382.86M	$3.02B	$6.81B	$23.29B
Dividend Yield	N/A	1.78%	2.68%	4.11%
P/E Ratio	44.13	19.27	25.79	31.66
Price / Sales	0.41	329.35	548.63	20.32
Price / Cash	4.83	56.53	46.33	24.53
Price / Book	0.71	4.22	10.77	4.74
Net Income	$10.76M	$64.45M	$3.57B	$1.07B
7 Day Performance	9.16%	2.25%	3.15%	0.99%
1 Month Performance	12.84%	1.75%	2.34%	0.96%
1 Year Performance	-32.76%	26.64%	33.41%	24.40%

USANA Health Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USNA USANA Health Sciences	2.5759 of 5 stars	$20.74 +5.4%	N/A	-35.8%	$382.86M	$925.26M	44.13	1,570	Analyst Forecast High Trading Volume
HLF Herbalife	4.2931 of 5 stars	$12.20 +2.5%	$17.80 +46.0%	+45.9%	$1.23B	$5.04B	5.35	8,500
NATR Nature's Sunshine Products	3.7821 of 5 stars	$20.40 +1.4%	$35.00 +71.6%	+39.3%	$353.81M	$489.79M	18.55	850	News Coverage Short Interest Increase
NUS Nu Skin Enterprises	2.3225 of 5 stars	$5.03 +0.1%	N/A	-36.3%	$243.72M	$1.49B	4.57	2,800
MED Medifast	1.9607 of 5 stars	$11.07 +0.3%	$12.00 +8.4%	-22.5%	$122.75M	$385.79M	N/A	870

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:USNA) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USANA Health Sciences (USNA) Competitors

USNA vs. HLF, NATR, NUS, MED, and VERU

How does USANA Health Sciences compare to Herbalife?

Summary

How does USANA Health Sciences compare to Nature's Sunshine Products?

Summary

How does USANA Health Sciences compare to Nu Skin Enterprises?

Summary

How does USANA Health Sciences compare to Medifast?

Summary

How does USANA Health Sciences compare to Veru?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USANA Health Sciences (USNA) Competitors

USNA vs. HLF, NATR, NUS, MED, and VERU

How does USANA Health Sciences compare to Herbalife?

Do institutionals & insiders have more ownership in HLF or USNA?

Which has better valuation and earnings, HLF or USNA?

Does the media favor HLF or USNA?

Is HLF or USNA more profitable?

Do analysts rate HLF or USNA?

Which has more volatility & risk, HLF or USNA?

Summary

How does USANA Health Sciences compare to Nature's Sunshine Products?

Do analysts prefer NATR or USNA?

Which has preferable earnings and valuation, NATR or USNA?

Does the media favor NATR or USNA?

Do institutionals & insiders hold more shares of NATR or USNA?

Is NATR or USNA more profitable?

Which has more volatility and risk, NATR or USNA?

Summary

How does USANA Health Sciences compare to Nu Skin Enterprises?

Does the media prefer NUS or USNA?

Do institutionals and insiders hold more shares of NUS or USNA?

Is NUS or USNA more profitable?

Do analysts recommend NUS or USNA?

Which has more volatility and risk, NUS or USNA?

Which has preferable valuation & earnings, NUS or USNA?

Summary

How does USANA Health Sciences compare to Medifast?

Do insiders and institutionals hold more shares of MED or USNA?

Does the media prefer MED or USNA?

Do analysts recommend MED or USNA?

Which has more risk & volatility, MED or USNA?

Is MED or USNA more profitable?

Which has stronger earnings and valuation, MED or USNA?

Summary

How does USANA Health Sciences compare to Veru?

Do analysts rate USNA or VERU?

Which has more risk & volatility, USNA or VERU?

Does the media favor USNA or VERU?

Do insiders & institutionals have more ownership in USNA or VERU?

Is USNA or VERU more profitable?

Which has preferable earnings & valuation, USNA or VERU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools